Logo

Ambry Genetics Neurodevelopmental Genetic Testing Panel

Jan 20, 2016

Ambry Genetics has launched a new suite of five genetic tests for neurodevelopmental conditions:

  • IDNext, a broad panel of 140 genes known to be associated with both syndromic and non-syndromic intellectual disability (ID)
  • AutismFirst, a targeted panel of 16 genes recognized by the American College of Medical Genetics and Genomics as associated with syndromic autism spectrum disorders (ASDs)
  • AutismNext, a broader panel of 48 genes that can cause both syndromic and non-syndromic ASDs
  • Neurodevelopment-Expanded, a broad panel of 196 genes designed for patients who have a combination of ID, ASDs, and epilepsy
  • Rett/AngelmanNext, a panel of 22 genes known to cause symptoms of multiple overlapping neurodevelopmental disorders, including Rett syndrome and Angelman syndrome.